The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Incidence of cerebral microbleeds in preclinical Alzheimer disease
Open accessAbstract
OBJECTIVE: We sought to determine the incidence and associations of lobar microbleeds (LMBs) in a longitudinal cohort with (11)C-Pittsburgh compound B (PiB) PET imaging. METHODS: One hundred seventy-four participants from the observational Australian Imaging, Biomarkers and Lifestyle Study of Ageing (97 with normal cognition [NC], 37 with mild cognitive impairment [MCI], and 40 with Alzheimer disease [AD] dementia) were assessed at 3 time points over 3 years with 3-tesla susceptibility-weighted MRI and (11)C-PiB PET. MRIs were inspected for microbleeds, siderosis, infarction, and white matter hyperintensity severity, blind to clinical and PiB findings. Neocortical PiB standardized uptake value ratio, normalized to cerebellar cortex, was dichotomized as positive or negative (PiB+/-, standardized uptake value ratio >1.5). Annualized LMB incidence was calculated, and logistic regression was used to determine the association of incident LMBs with PiB, APOE ε4+ status, and cerebrovascular disease. RESULTS: LMBs were present in 18.6% of NC, 24.3% of MCI, and 40% of AD participants (p < 0.05 vs NC). LMB incidence was 0.2 ± 0.6 per year in NC participants, 0.2 ± 0.5 in MCI, and 0.7 ± 1.4 in AD (p < 0.03 vs NC) and was 6-fold higher in PiB+ than PiB-NC. Incident LMBs were associated with age, APOE ε4+, PiB+, and baseline LMBs. Incidence of multiple LMBs was also associated with lacunar infarction and white matter hyperintensity severity. CONCLUSIONS: Older age, baseline LMBs, higher β-amyloid burden, and concomitant cerebrovascular disease may all confer higher risk of incident LMBs. This should be considered when designing protocols for amyloid-modifying clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This broad range of detection could likely be attributed to the magnet field strength, with clinical strength 1.5 and 3T magnets likely underestimating the incidence of microbleeds compared with the research-grade 7T magnet (83, 246, 452, 530, 604, 669).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [669]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, the risk of brain microhemorrhages related to Aβ immunotherapy may be a transient complication and possibly reduced in individuals with modest VAβ burden, who also have lower prevalence of spontaneous microbleeds [58, 59].”
From APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice (2017) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“CNS microbleeds reflect loss of cerebrovascular integrity and are found in 25% of individuals with MCI (669) and 45-78% of individuals with early AD without dementia (83, 208, 246, 452, 476, 529, 604, 702).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [669]
The cited source says what the claim attributes to it.
In the citing paper
“Both VAβ and hypertensive or atherosclerotic microangiopathy are recognized clinical risk factors for cerebral microbleeds, with the former correlating stronger with bleeding in cortical/subcortical distribution [58, 59] while the later with bleeding to deep brain structures including basal ganglia and thalamic nuclei [60, 61].”
From APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice (2017) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citationMR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging
Fazekas, F., Chawluk, J. B., Alavi, A. A., Hurtig, H. I., & Zimmerman, R. A. (1987) · American Journal of Roentgenology · doi:10.2214/ajr.149.2.351 · Cited by 5,327
Cerebral microbleeds: a guide to detection and interpretation
Greenberg, S. M., Vernooij, M. W., Cordonnier, C., Viswanathan, A., Al-Shahi Salman, R., Warach, S., Launer, L. J., Van Buchem, M. A., & Breteler, M. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70013-4 · Cited by 1,798
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria
Knudsen, K. A., Rosand, J., Karluk, D., & Greenberg, S. M. (2001) · Neurology · doi:10.1212/wnl.56.4.537 · Cited by 1,015
Ellis, K. A., Bush, A. I., Darby, D., Fazio, D. D., Foster, J. K., Hudson, P. J., Lautenschlager, N. T., Lenzo, N. P., Martins, R. N., Maruff, P. T., et al. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209009405 · Cited by 1,005
Self-citationAmyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986
Self-citation
Cited by
Sorted by citations
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Establishment and Dysfunction of the Blood-Brain Barrier
Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670
White matter hyperintensities, cognitive impairment and dementia: an update
Prins, N. D., & Scheltens, P. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.10 · Cited by 1,284
The role of brain vasculature in neurodegenerative disorders
Sweeney, M. D., Kisler, K., Montagne, A., Toga, A. W., & Zlokovic, B. V. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0234-x · Cited by 998
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0281-2 · Cited by 947
Alzheimer’s disease: A matter of blood–brain barrier dysfunction?
Montagne, A., Zhao, Z., & Zlokovic, B. V. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171406 · Cited by 672
Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease
Nelson, A. R., Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.016 · Cited by 559
Alzheimer’s Disease Genetics: From the Bench to the Clinic
Karch, C. M., Cruchaga, C., & Goate, A. M. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.041 · Cited by 473
Age-associated Physiological and Pathological Changes at the Blood-Brain Barrier: A Review
Erdő, F., Denes, L., & de Lange, E. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16679420 · Cited by 426
Genes associated with Alzheimer's disease: an overview and current status
Giri, M., Lü, Y., & Zhang, M. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s105769 · Cited by 311
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Van Acker, Z. P., Bretou, M., & Annaert, W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0323-7 · Cited by 222
Pietrzak, R. H., Lim, Y. Y., Neumeister, A., Ames, D., Ellis, K. A., Harrington, K., Lautenschlager, N. T., Restrepo, C., Martins, R. N., Masters, C. L., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2476 · Cited by 214
Self-citationCerebral microhemorrhages: mechanisms, consequences, and prevention
Ungvari, Z. I., Tarantini, S., Kirkpatrick, A. C., Csiszár, A., & Prodan, C. I. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00780.2016 · Cited by 174
Fowler, C., Rainey-Smith, S. R., Bird, S., Bomke, J., Bourgeat, P., Brown, B. M., Burnham, S. C., Bush, A. I., Chadunow, C., Collins, S., et al. (2021) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-210005 · Cited by 164
Self-citationCerebral small vessel disease: neuroimaging markers and clinical implication
Chen, X., Wang, J., Shan, Y., Cai, W., Liu, S., Hu, M., Liao, S., Huang, X., Zhang, B., Wang, Y., et al. (2018) · Journal of Neurology · doi:10.1007/s00415-018-9077-3 · Cited by 166
Blood–brain barrier link to human cognitive impairment and Alzheimer’s disease
Barisano, G., Montagne, A., Kisler, K., Schneider, J. A., Wardlaw, J. M., & Zlokovic, B. V. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-021-00014-4 · Cited by 157
Associations between amyloid β and white matter hyperintensities: A systematic review
Roseborough, A. D., Ramirez, J., Black, S. E., & Edwards, J. D. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.01.026 · Cited by 139
Appraising the Role of Iron in Brain Aging and Cognition: Promises and Limitations of MRI Methods
Daugherty, A. M., & Raz, N. (2015) · Neuropsychology Review · doi:10.1007/s11065-015-9292-y · Cited by 133
Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance
Nehra, G., Bauer, B., & Hartz, A. M. S. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108119 · Cited by 127
Risk Factors Associated With Early vs Delayed Dementia After Intracerebral Hemorrhage
Biffi, A., Bailey, D., Anderson, C. D., Ayres, A. M., Gurol, M. E., Greenberg, S. M., Rosand, J. M., & Viswanathan, A. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.0955 · Cited by 124
Cerebral small vessel disease and Alzheimer’s disease
Cai, Z., Wang, C., He, W., Tu, H., Tang, Z., Xiao, M., & Yan, L. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s90871 · Cited by 102
Csiszar, A., Tarantini, S., Fülöp, G. A., Kiss, T., Valcarcel-Ares, M. N., Galvan, V., Ungvari, Z., & Yabluchanskiy, A. (2017) · GeroScience · doi:10.1007/s11357-017-9991-9 · Cited by 93
The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer’s Disease of humans and mice
Cacciottolo, M., Christensen, A., Moser, A., Liu, J., Pike, C., Smith, C., LaDu, M., Sullivan, P., Morgan, T., Dolzhenko, E., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.010 · Cited by 93
Tau at the interface between neurodegeneration and neuroinflammation
Didonna, A. (2020) · Genes & Immunity · doi:10.1038/s41435-020-00113-5 · Cited by 82
Cerebral blood flow changes during aging process and in cognitive disorders: A review
Mokhber, N., Shariatzadeh, A., Avan, A., Saber, H., Babaei, G., Chaimowitz, G. A., & Azarpazhooh, M. R. (2021) · The Neuroradiology Journal · doi:10.1177/19714009211002778 · Cited by 97
Neural stem cell therapy for neurovascular injury in Alzheimer's disease
Boese, A. C., Hamblin, M. H., & Lee, J. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113112 · Cited by 89
Interactions between glial cells and the blood-brain barrier and their role in Alzheimer's disease
Zhao, M., Jiang, X., Zhang, H., Sun, J., Pei, H., Ma, L., Cao, Y., & Li, H. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101483 · Cited by 85
Pietrzak, R. H., Lim, Y. Y., Ames, D. J., Harrington, K., Restrepo, C., Martins, R. N., Rembach, A., Laws, S. M., Masters, C. L., Villemagne, V. L., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.015 · Cited by 88
Self-citationFarid, K., Charidimou, A., & Baron, J. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.05.002 · Cited by 86
Microvascular Alterations in Alzheimer's Disease
Steinman, J., Sun, H., & Feng, Z. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.618986 · Cited by 85
Poon, C., Shah, K., Lin, C., Tse, R., Kim, K. K., Mooney, S. J., Aubert, I., Stefanovic, B., & Hynynen, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-32250-3 · Cited by 83
Ting, K. K., Coleman, P. R., Kim, H. J., Zhao, Y., Mulangala, J., Cheng, N. C., Li, W., Gunatilake, D., Johnstone, D. M., Loo, L., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00927-x · Cited by 81
Basal lamina changes in neurodegenerative disorders
Nguyen, B., Bix, G., & Yao, Y. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00502-y · Cited by 75
Carter, C. (2017) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170017 · Cited by 74
GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight
Monti, G., Moreira, D. G., Richner, M., Mutsaers, H. A. M., Ferreira, N., & Jan, A. (2022) · Cells · doi:10.3390/cells11132023 · Cited by 72
Addressing Blood–Brain Barrier Impairment in Alzheimer’s Disease
Sharma, C., Woo, H., & Kim, S. R. (2022) · Biomedicines · doi:10.3390/biomedicines10040742 · Cited by 71
Cerebrovascular Disease, Amyloid Plaques, and Dementia
Liu, W., Wong, A., Law, A. C. K., & Mok, V. (2015) · Stroke · doi:10.1161/strokeaha.114.006571 · Cited by 71
Sepehry, A. A., Lang, D. J., Hsiung, G. R., & Rauscher, A. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4525 · Cited by 69
Giorgi, F. S., Galgani, A., Puglisi‐Allegra, S., Limanaqi, F., Busceti, C. L., & Fornai, F. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24718 · Cited by 69
Fujishima, M., Maikusa, N., Nakamura, K., Nakatsuka, M., Matsuda, H., & Meguro, K. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00306 · Cited by 68
Pietrzak, R. H., Laws, S. M., Lim, Y. Y., Bender, S. J., Porter, T., Doecke, J. D., Ames, D. J., Fowler, C. J., Masters, C. L., Milicic, L., et al. (2016) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2016.08.006 · Cited by 64
Self-citationAPOE and cortical superficial siderosis in CAA
Charidimou, A., Zonneveld, H. I., Shams, S., Kantarci, K., Shoamanesh, A., Hilal, S., Yates, P. A., Boulouis, G., Na, H. K., Pasi, M., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007818 · Cited by 60
Self-citationThe role of CD2AP in the Pathogenesis of Alzheimer's Disease
Tao, Q.-Q., Chen, Y.-C., & Wu, Z.-Y. (2019) · Aging and disease · doi:10.14336/ad.2018.1025 · Cited by 61
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
ten Kate, M., Ingala, S., Schwarz, A. J., Fox, N. C., Chételat, G., van Berckel, B. N. M., Ewers, M., Foley, C., Gispert, J. D., Hill, D., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0438-z · Cited by 65
Esiri, M. M., Chance, S. A., Joachim, C. L., Warden, D. R., Smallwood, A., Sloan, C., Christie, S., Wilcock, G. K., & Smith, A. D. (2014) · Brain Pathology · doi:10.1111/bpa.12221 · Cited by 56
Nyúl‐Tóth, Á., Tarantini, S., Kiss, T., Tóth, P., Galván, V., Tarantini, A., Yabluchanskiy, A., Csiszár, A., & Ungvari, Z. I. (2020) · GeroScience · doi:10.1007/s11357-020-00256-3 · Cited by 52
Malhotra, K., Theodorou, A., Katsanos, A. H., Zompola, C., Shoamanesh, A., Boviatsis, E., Paraskevas, G. P., Spilioti, M., Cordonnier, C., Werring, D. J., et al. (2022) · Stroke · doi:10.1161/strokeaha.121.035836 · Cited by 51
Moda, F., Ciullini, A., Dellarole, I. L., Lombardo, A., Campanella, N., Bufano, G., Cazzaniga, F. A., & Giaccone, G. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2810255 · Cited by 49
Disease progression and regression in sporadic small vessel disease–insights from neuroimaging
van Leijsen, E. M. C., de Leeuw, F., & Tuladhar, A. M. (2017) · Clinical Science · doi:10.1042/cs20160384 · Cited by 50
Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles
Islam, Y., Leach, A. G., Smith, J. A., Pluchino, S., Coxon, C. R., Sivakumaran, M., Downing, J. R., Fatokun, A. A., Teixidò, M., & Ehtezazi, T. (2021) · Advanced Science · doi:10.1002/advs.202002085 · Cited by 52
Abla, A. A., Nelson, J., Kim, H., Hess, C. P., Tihan, T., & Lawton, M. T. (2015) · Neurosurgery · doi:10.1227/neu.0000000000000686 · Cited by 50
Are the brain's vascular and Alzheimer pathologies additive or interactive?
Koncz, R., & Sachdev, P. S. (2017) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000395 · Cited by 47
Wang, Y., Jiang, Y., Suo, C., Yuan, Z., Xu, K., Yang, Q., Tang, W., Zhang, K., Zhu, Z., Tian, W., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101749 · Cited by 45
Biomarkers Assessing Endothelial Dysfunction in Alzheimer’s Disease
Custodia, A., Aramburu-Núñez, M., Rodríguez‐Arrizabalaga, M., Peleteiro, J. M. P., Vázquez‐Vázquez, L., Camino-Castiñeiras, J., Aldrey, J. M., Castillo, J., Ouro, A., Sobrino, T., et al. (2023) · Cells · doi:10.3390/cells12060962 · Cited by 47
Potential Role of Venular Amyloid in Alzheimer’s Disease Pathogenesis
Morrone, C. D., Bishay, J., & McLaurin, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061985 · Cited by 43
Endothelial Progenitor Cells and Vascular Alterations in Alzheimer’s Disease
Custodia, A., Ouro, A., Romaus‐Sanjurjo, D., Peleteiro, J. M. P., de Vries, H. E., Castillo, J., & Sobrino, T. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.811210 · Cited by 45
Petralla, S., Panayotova, M., Franchina, E., Fricker, G., & Puris, E. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070948 · Cited by 46
Liu, J., Xia, S., Hanks, R. A., Wiseman, N. M., Peng, C., Zhou, S., Haacke, E. M., & Kou, Z. (2015) · Journal of Neurotrauma · doi:10.1089/neu.2014.3856 · Cited by 41
Computer-aided detection of cerebral microbleeds in susceptibility-weighted imaging
Fazlollahi, A., Mériaudeau, F., Giancardo, L., Villemagne, V. L., Rowe, C. C., Yates, P. A., Salvado, O., & Bourgeat, P. (2015) · Computerized Medical Imaging and Graphics · doi:10.1016/j.compmedimag.2015.10.001 · Cited by 38
Self-citationSynergistic effects of longitudinal amyloid and vascular changes on lobar microbleeds
Kim, Y. J., Kim, Y. J., Park, J., Kim, S., Woo, S., Kwak, K., Lee, J. M., Kim, Y. J., Kim, J. S., Choe, Y. S., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003220 · Cited by 36
Pankiewicz, J. E., Baquero-Buitrago, J., Sanchez, S., Lopez-Contreras, J., Kim, J., Sullivan, P. M., Holtzman, D. M., & Sadowski, M. J. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0156-1 · Cited by 34
“Thus, the risk of brain microhemorrhages related to Aβ immunotherapy may be a transient complication and possibly reduced in individuals with modest VAβ burden, who also have lower prevalence of spontaneous microbleeds [58, 59].”
BackgroundComplete Evaluation of Dementia: PET and MRI Correlation and Diagnosis for the Neuroradiologist
Oldan, J. D., Jewells, V. L., Pieper, B., & Wong, T. Z. (2021) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7079 · Cited by 34
Cerebral Microbleeds as a Biomarker in Alzheimer’S Disease? A Review in The Field
Shams, S., & Wahlund, L.-O. (2016) · Biomarkers in Medicine · doi:10.2217/bmm.15.101 · Cited by 32
Beaman, C. B., Kozii, K., Hilal, S., Liu, M., Spagnolo‐Allende, A., Serra, G. P., Chen, C., Cheng, C., Zambrano, D., Arikan, B., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200142 · Cited by 32
Ungvari, Z. I., Yabluchanskiy, A., Tarantini, S., Tóth, P., Kirkpatrick, A. C., Csiszár, A., & Prodan, C. I. (2018) · GeroScience · doi:10.1007/s11357-018-0044-9 · Cited by 28
Genetic heterogeneity of Alzheimer’s disease in subjects with and without hypertension
Nazarian, A., Arbeev, K. G., Yashkin, A. P., & Kulminski, A. M. (2019) · GeroScience · doi:10.1007/s11357-019-00071-5 · Cited by 27
Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease
Joseph‐Mathurin, N., Wang, G., Kantarci, K., Jack, C. R., McDade, E., Hassenstab, J. J., Blazey, T., Gordon, B. A., Su, Y., Chen, G., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011542 · Cited by 28
Self-citationLove, S., & Miners, J. S. (2017) · Clinical Science · doi:10.1042/cs20170148 · Cited by 25
Ingala, S., Mazzai, L., Sudre, C. H., Salvadó, G., Brugulat-Serrat, A., Wottschel, V., Falcon, C., Operto, G., Tijms, B., Gispert, J. D., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.06.015 · Cited by 25
Tanaka, T., Stephenson, M. C., Nai, Y., Khor, D., Saridin, F. N., Hilal, S., Villaraza, S. G., Gyanwali, B., Ihara, M., Vrooman, H. A., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04642-8 · Cited by 22
Beckmann, N., Doelemeyer, A., Zurbruegg, S., Bigot, K., Theil, D. J., Frieauff, W., Kolly, C., Moulin, P., Neddermann, D., Kreutzer, R., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.05.009 · Cited by 24
Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease
Nelson, A. R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.858429 · Cited by 24
Whitwell, J. L., Kantarci, K., Weigand, S. D., Lundt, E. S., Gunter, J. L., Duffy, J. R., Strand, E. A., Machulda, M. M., Spychalla, A. J., Drubach, D. A., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142628 · Cited by 22
A functional cerebral endothelium is necessary to protect against cognitive decline
Trigiani, L. J., Bourourou, M., Lacalle-Aurioles, M., Lecrux, C., Hynes, A., Spring, S., Fernandes, D. J., Sled, J. G., Lesage, F., Schwaninger, M., et al. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211045438 · Cited by 21
Xu, L., Zhao, Y., Choi, S., Li, M., Schilling, K. G., Zu, Z., Rogers, B. P., Ding, Z., Anderson, A. W., Landman, B. A., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14334 · Cited by 20
Age, sex, and cerebral microbleeds in EFAD Alzheimer disease mice
Cacciottolo, M., Morgan, T. E., & Finch, C. E. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.02.020 · Cited by 20
Padrela, B. E., Mahroo, A., Tee, M., Sneve, M. H., Moyaert, P., Geier, O. M., Kuijer, J. P. A., Beun, S., Nordhøy, W., Zhu, Y. D., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-081635 · Cited by 19
Saiyasit, N., Butlig, E.-A. R., Chaney, S. D., Traylor, M. K., Hawley, N. A., Randall, R. B., Bobinger, H. V., Frizell, C. A., Trimm, F., Crook, E. D., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.915405 · Cited by 22
Clinicoradiologic Correlations of Cerebral Microbleeds in Advanced Age
Barnaure, I., Montandon, M.-L., Rodriguez, C. K., Herrmann, F. R., Lövblad, K., Giannakopoulos, P., & Haller, S. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4956 · Cited by 19
Common Impact of Chronic Kidney Disease and Brain Microhemorrhages on Cerebral Aβ Pathology in SHRSP
Pirici, D. N., Stanaszek, L., Garz, C., Niklass, S., Heinze, H., Kalinski, T., Attems, J., & Schreiber, S. (2016) · Brain Pathology · doi:10.1111/bpa.12384 · Cited by 19
Nanomedicine against Alzheimer’s and Parkinson’s Disease
Tandon, A., Singh, S. J., & Chaturvedi, R. K. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201021140904 · Cited by 20
Classification differentiates clinical and neuroanatomic features of cerebral small vessel disease
Chou, K., Lee, P., Peng, L., Lee, W., Wang, P., Chen, L., Lin, C., & Chung, C. (2021) · Brain Communications · doi:10.1093/braincomms/fcab107 · Cited by 18
Chin, K. S., Holper, S., Loveland, P. M., Churilov, L. P., Yassi, N., & Watson, R. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.11.006 · Cited by 18
Widespread brain transcriptome alterations underlie the neuroprotective actions of dietary saffron
Skladnev, N. V., Ganeshan, V., Kim, J. Y., Burton, T. J., Mitrofanis, J., Stone, J., & Johnstone, D. M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13857 · Cited by 17
Bergeron, S., Chen, Y. S., Auger, F., Deguil, J., Durieux, N., Skrobala, E., Barus, R., Potey, C., Cordonnier, C., Pasquier, F., et al. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17752765 · Cited by 17
Gan, J., Yang, X., Zhang, G., Li, X., Liu, S., Zhang, W., & Ji, Y. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1088140 · Cited by 17
Chatanaka, M. K., Sohaei, D., Diamandis, E. P., & Prassas, I. (2023) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2023.2187342 · Cited by 15
Basselerie, H., Bracoud, L., Zeestraten, E., Bouguen, E., Kiyasova, V., Pueyo, M. E., Cognard, C., Dumas, H., Gramada, R., Ousset, P., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170470 · Cited by 19
Strictly Lobar Cerebral Microbleeds Are Associated with Increased White Matter Volume
Wang, P., Chou, K., Peng, L., Liu, L.-K., Lee, W., Chen, L., Lin, C., & Chung, C. (2019) · Translational Stroke Research · doi:10.1007/s12975-019-00704-z · Cited by 15
Rauchmann, B., Ghaseminejad, F., Mekala, S., Perneczky, R., & Initiative, A. D. N. (2020) · Radiology · doi:10.1148/radiol.2020191904 · Cited by 14
Cerebrovascular Dysfunction in Alzheimer’s Disease and Transgenic Rodent Models
Fang, X., Fan, F., & Roman, R. J. (2024) · Journal of Experimental Neurology · doi:10.33696/neurol.5.087 · Cited by 17
Zsadanyi, S. E., Morcillo-Nieto, A. O., Aranha, M. R., Aragón, I., Arriola‐Infante, J. E., Vaqué‐Alcázar, L., Montal, V., Pegueroles, J., Arranz, J., Rodríguez‐Baz, Í., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209676 · Cited by 15
Brutto, Ó. H. D., Mera, R. M., Ha, J., Brutto, V. J. D., Castillo, P. R., Zambrano, M., & Gillman, J. A. M. (2015) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0473-6 · Cited by 13
Nociceptive Primitive Reflexes in Neurologically and Cognitively Healthy Aging Subjects
Camarda, C., Torelli, P., Pipia, C., Azzarello, D. M., Battaglini, I., Sottile, G., Cilluffo, G., & Camarda, R. (2019) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2018.388 · Cited by 13
Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort
Costa, A. S., Pinho, J., Kučikienė, D., Reich, A., Schulz, J. B., & Reetz, K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201218 · Cited by 13
Kou, Z., Ye, Y., & Haacke, E. M. (2015) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000064 · Cited by 11
Shi, M., Li, C., Tian, X., Chu, F., & Zhu, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.685863 · Cited by 13
Magnetic Resonance Imaging of Vascular Contributions to Cognitive Impairment and Dementia
Yassi, N., Desmond, P. M., & Masters, C. L. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0799-3 · Cited by 12
Self-citationCognitive Impairment in Cerebral Amyloid Angiopathy: A Single-Center Prospective Cohort Study
Theodorou, A., Athanasaki, A., Melanis, K., Pachi, I., Sterpi, A.-E., Koropouli, E., Bakola, E., Chondrogianni, M. E., Stefanou, M., Vasilopoulos, E., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237427 · Cited by 10
Metadata
- Authors
- Yates, P. A., Desmond, P. M., Phal, P. M., Steward, C., Szoeke, C., Salvado, O., Ellis, K. A., Martins, R. N., Masters, C. L., Ames, D., Villemagne, V. L., Rowe, C. C., & For the AIBL Research Group
- Affiliations
- Edith Cowan University (AU)
- ORCID
- Venue
- Neurology
- Published
- 2014-04-08
- Volume
- 82
- Issue
- 14
- Pages
- 1266-1273
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC4001205
- OpenAlex
- W1992608632
- Cited by
- 150
- References
- 41
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 9 · 2023: 7 · 2022: 16 · 2021: 16 · 2020: 11 · 2019: 13 · 2018: 10 · 2017: 12 · 2016: 13 · 2015: 20 · 2014: 7
- FWCI
- 13.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Bank (Australian Catholic University) (submittedVersion)
- Research Online (Edith Cowan University) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- Eli Lilly and Company
- Pfizer
- Commonwealth Scientific and Industrial Research Organisation
- Dementia Collaborative Research Centres, Australia
- H. Lundbeck A/S
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- cerebral microbleeds, lobar microbleeds, preclinical Alzheimer's disease, mild cognitive impairment, amyloid PET, APOE ε4, cerebrovascular disease, lacunar infarction, white matter hyperintensities
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Amyloid, Aniline Compounds, Australia, Brain, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Thiazoles, Incidence, Intracranial Hemorrhages, Positron-Emission Tomography, Cerebral Small Vessel Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
